Immatics
upcoming catalysts for and clinical lead assets | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
4 of 75
Related slides by other companies
Third Harmonic Bio
IPO
September 2022
multiple upcoming clinical catalysts | Third Harmonic Bio
Kiromic BioPharma
Investor Presentation
May 2023
upcoming milestones authorization to evaluate in non small cell lung cancer may beginning of first in human trial activation for data results from first patient in clinical trial by end of initiation of clinical trials expansion cohort submission of new for and | Kiromic BioPharma
Talkspace
SPAC
January 2021
science based approach leads to superior clinical outcome talk space | Talkspace
Aeglea BioTherapeutics
Investor Presentation
September 2023
spy is a potentially best in class anti a with near term risking studies anticipated | Aeglea BioTherapeutics
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights